The latest report by IMARC Group, titled “Artificial Intelligence in Healthcare Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global artificial intelligence in healthcare market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 23.9 Billion by 2028, exhibiting a growth rate (CAGR) of 29.8% during 2023-2028. 

Factors Affecting the Growth of Artificial Intelligence in Healthcare Industry:

  • Rapid Advancements in Medical Technology and Data Generation:

One of the primary drivers of the global artificial intelligence in healthcare learning market is the rapid advancements in medical technology and the exponential growth in healthcare data generation. The healthcare industry has witnessed a rise in the adoption of electronic health records (EHRs), wearable devices, and medical imaging technologies. These technologies generate vast amounts of patient data, which can be harnessed and analyzed by AI systems. AI-powered algorithms can sift through this data to identify trends, anomalies, and potential health risks, leading to more accurate diagnoses, treatment plans, and personalized medicine. Additionally, the integration of AI-driven predictive analytics in healthcare can assist in early disease detection, making healthcare more proactive and cost-effective. As healthcare providers increasingly recognize the potential of AI in improving patient outcomes, the demand for AI-powered solutions continues to rise.

  • Growing Need for Efficient Healthcare Delivery:

The second major factor propelling the adoption of artificial intelligence in healthcare learning is the growing need for more efficient healthcare delivery. Healthcare systems worldwide face numerous challenges, including rising healthcare costs, a shortage of healthcare professionals, and an aging population. AI in healthcare can address these challenges by streamlining administrative tasks, automating routine processes, and assisting medical professionals in making faster and more informed decisions. AI-driven chatbots and virtual health assistants can handle appointment scheduling, answer patient queries, and provide real-time health information, reducing the burden on healthcare staff. Moreover, AI can help in optimizing hospital operations, predicting patient admissions, and managing healthcare resources more effectively. This increased efficiency in healthcare delivery is attracting investment in AI technologies across the industry.

  • Advancements in Machine Learning Algorithms and Computational Power:

The third significant factor propelling the global artificial intelligence in healthcare learning market is the continuous advancements in machine learning algorithms and computational power. Machine learning techniques, such as deep learning, have shown remarkable potential in analyzing complex healthcare data, including medical images, genomics, and patient records. With the availability of high-performance computing resources and cloud-based AI platforms, healthcare organizations can harness the full potential of AI. These developments have led to the creation of AI models that can predict disease progression, recommend personalized treatment plans, and identify novel drug candidates. As AI algorithms become more sophisticated and reliable, the healthcare industry is increasingly leveraging these capabilities to enhance patient care, reduce medical errors, and drive research and innovation.

Competitive Landscape with Key Player:

  • Amazon Web Services Inc.
  • Cloudmedx Inc.
  • DeepMind
  • Enlitic Inc.
  • General Vision Inc.
  • Google Inc.
  • International Business Machines
  • iCarbonX
  • Intel Corporation
  • Medtronic
  • Micron Technology Inc.
  • Microsoft Corporation
  • Next It Corporation
  • Nuance Communications Inc.
  • Nvidia Corporation
  • Siemens Healthcare
  • Welltok Inc.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artifical-intelligence-healthcare-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Offering:

  • Hardware
  • Software
  • Services

Software dominates the market due to its pivotal role in enabling data analysis, decision support, and the development of innovative healthcare solutions.

Breakup by Technology:

  • Machine Learning
  • Context-Aware Computing
  • Natural Language Processing
  • Others

Machine learning holds maximum number of shares due to its ability to analyze vast healthcare datasets and deliver valuable insights for improved patient care and operational efficiency.

Breakup by Application:

  • Robot-Assisted Surgery
  • Virtual Nursing Assistant
  • Administrative Workflow Assistance
  • Fraud Detection
  • Dosage Error Reduction
  • Clinical Trial Participant Identifier
  • Preliminary Diagnosis
  • Others

Clinical trial participant identifier represents the largest segment due to their crucial role in ensuring accurate and efficient data management and patient tracking, enhancing the overall efficiency and reliability of clinical trials.

Breakup by End-User:

  • Healthcare Providers
  • Pharmaceutical and Biotechnology Companies
  • Patients
  • Others

Pharmaceutical and biotechnology dominates the market due to its significant investments in AI-driven research, drug discovery, and personalized medicine solutions.

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America’s dominance in the artificial intelligence healthcare market is attributed to its robust economic infrastructure and diverse consumer base, making it a prime market for various industries and businesses.

Global Artificial Intelligence in Healthcare Market Trends:

The increasing availability of vast healthcare data sets, including electronic health records, medical imaging, and wearable device data, has provided ample resources for training AI algorithms, enhancing their predictive capabilities. Additionally, rapid advancements in AI technology, including machine learning and natural language processing, have paved the way for more accurate diagnosis, treatment recommendations, and patient management. Other than this, AI-driven solutions can streamline administrative tasks, optimize resource allocation, and reduce healthcare costs, making it an attractive option for healthcare providers and payers. Besides this, governments and regulatory bodies are recognizing the potential of AI in healthcare and are creating frameworks to encourage its responsible adoption, further propelling market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163